Venus Concept (NASDAQ:VERO) Stock Price Down 0.5% – What’s Next?

Venus Concept Inc. (NASDAQ:VERO)’s share price was down 0.5% during trading on Thursday . The stock traded as low as $1.82 and last traded at $1.84. Approximately 29,357 shares were traded during trading, a decline of 31% from the average daily volume of 42,785 shares. The stock had previously closed at $1.85.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Venus Concept in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Venus Concept currently has an average rating of “Sell”.

Venus Concept Price Performance

The stock has a 50 day moving average of $2.06 and a 200-day moving average of $2.30. The company has a current ratio of 0.90, a quick ratio of 0.59 and a debt-to-equity ratio of 1.59. The stock has a market capitalization of $2.66 million, a P/E ratio of -0.04 and a beta of -0.11.

Venus Concept (NASDAQ:VERO) last announced its quarterly earnings results on Thursday, November 13th. The company reported ($12.14) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.61) by ($8.53). Venus Concept had a negative net margin of 92.76% and a negative return on equity of 1,904.25%. The firm had revenue of $13.78 million during the quarter, compared to analysts’ expectations of $14.48 million.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.